C12P 21 - Preparation of peptides or proteins

Patents for C12P 21 - Preparation of peptides or proteins (112,499)
12/2004
12/09/2004	US20040248324 Fhm a novel member of the TNF ligand supergene family: materials and methods for interaction modulators
12/09/2004	US20040248262 Nucleotide sequences coding lysosomal protein for use treatment of brain and muscular disorders
12/09/2004	US20040248258 Methods for producing secreted polypeptides
12/09/2004	US20040248256 Secreted proteins and polynucleotides encoding them
12/09/2004	US20040248253 Methods and compositions for polypeptide engineering
12/09/2004	US20040248252 Nucleotide sequences coding mammalian histamine H4 receptor protein for use in diagnosis, prevention and treatment of asthma, allergy, inflammation, thrombotic, cardiovascular and autoimmune disorders
12/09/2004	US20040248251 Receptors and membrane associated proteins
12/09/2004	US20040248249 Protein for use in treatment, prevention and diagnosis of cell proliferative, autoimmune/inflammatory, cardiovascular, neurological, and developmental disorders
12/09/2004	US20040248241 Compositions and methods for eliciting an immune response to Gram-negative bacterial infections
12/09/2004	US20040248240 Nucleotide sequences coding membrane protein for use in identifying modulator for treatment of pain management, epilepsy, stroke, ischemia and heart disease
12/09/2004	US20040248239 Method for producing amino acid components by enzymatic hydrolysis of fish egg skin
12/09/2004	US20040248238 Method for increasing the solubility, expression rate and the acitivity of proteins during recombinant production
12/09/2004	US20040248231 Using reduction in beta site amyloid precursor protein cleaving enzyme activity, manifested as decreased beta amyloid peptides production, as diagnostic indicator of enzyme inhibition; for use in treatment of amyloid deposition disorders
12/09/2004	US20040248220 Using cadherin expression as diagnostic and prognostic indicator of tumor cell expression and/or progression
12/09/2004	US20040248219 Methods for diagnosing and evaluating cancer
12/09/2004	US20040248215 Immunoglobulin fusion comprising human chorionic gonadotropin component for use in treatment and prevention of viral infection and cell proliferative disorders
12/09/2004	US20040248180 Nucleotide sequences coding modified chromgenic and/or fluorescent protein for use as diagnostic indicators in genetic engineering
12/09/2004	US20040248178 Nucleotide sequences coding neuronal outgrowth and stability protein for use in treating ovarian, renal, neurological, cell proliferative and cardiovascular disorders
12/09/2004	US20040248173 Nucleotide sequences coding cyclic peptide receptor for use in identifying modulators for treatment of pituitary hormone, epinephrine release, gastrointestinal, cardiovascular, electrolyte balance, hypertensive, diabetic and respiratory system disorder
12/09/2004	US20040248155 Novel oncogene, recombinant protein derived therefrom, and uses thereof
12/09/2004	US20040248143 Generating novel polypeptides via non-stochastic polynucleotide site-saturation mutagenesis; protein bioengineering
12/09/2004	US20040248140 Nucleotidic sequences having activity of controlling translation efficiency and utilization thereof
12/09/2004	US20040248139 Eit-6, a polypeptide encoded by an estrogen regulated gene
12/09/2004	US20040248137 Human and mammalian stem cell-derived neuron survival polypeptides
12/09/2004	US20040248129 Neural polypeptide for use as tool in identifying modulators for controlling body weight; treating obesity
12/09/2004	US20040248124 Nucleic acid encoding polypeptide involved in cellular entrance of the prrs virus
12/09/2004	US20040248115 Nucleotide sequence probes for detecting beer-spoilage lactic acid bacteria; food processing and alcoholic beverages
12/09/2004	US20040247691 wound healing and tissue forming compositions with suitable cells affixed to prosthetic devices; microbeads are prepared by coagulation and emulsification of fibrinogen, thrombin and factor XIII without gluteraldehyde as a crosslinking agent
12/09/2004	US20040247621 Combination therapy using a synergistic mixture of mechlorethamine, nitrogen mustard N-oxide, melphalan, uramustin, ifosfamide, chlorambucil, or cyclophosphamide and an anti-interleukin-6 receptor antibody; anticarcinogenic agents
12/09/2004	US20040247616 Homologous 28-kilodalton immunodominant protein genes of Ehrlichia canis and uses thereof
12/09/2004	US20040247612 Immunogenic peptide composition for the prevention and treatment of Alzheimer's Disease
12/09/2004	US20040247605 Wall teichoic acid as a target for anti-staphylococcal therapies and vaccines
12/09/2004	US20040247599 Modulators of the P2Y10 receptor useful in altering T lymphocyte function
12/09/2004	US20040247595 Related to the potassium channel subfamily; can be used as models for the development of and aid in the identification of therapeutic proteins that modulate transporter activity
12/09/2004	US20040247588 Lyophilizing a solution of a modified antibody (especially Certolizumab Pegol) containing molecules capable of adversely affecting the stability or solubility of the antibody after lyophilization and from which some of those moledules have been removed
12/09/2004	US20040247562 Diagnostic and prognostic method for cancer based on skipping of the exon 3 region of the G-CSF gene at mRNA or protein levels
12/09/2004	CA2523716A1 Human anti-human cd3 binding molecules
12/08/2004	EP1484412A2 Eukaryotic host cell line in which an endogenous gene has been activated, and uses thereof
12/08/2004	EP1484404A1 Immunogenic detoxified mutants of cholera toxin and of the toxin LT, their preparation and their use for the preparation of vaccines
12/08/2004	EP1484402A2 Antibody for use in therapy
12/08/2004	EP1484400A1 Sodium-independent transporter carrying acidic amino acid and its gene
12/08/2004	EP1484340A1 Antibodies to a novel mammalian protein associated with uncontrolled cell division
12/08/2004	EP1484339A2 Kallikrein-inhibiting "Kunitz Domain" proteins and nucleic acids encoding the same
12/08/2004	EP1484338A1 Methods and compositions for inhibiting neoplastic cell growth
12/08/2004	EP1483397A2 Oligomeric molecules and uses thereof
12/08/2004	EP1483381A2 Variants of human kallikrein-2 and kallikrein-3 and uses thereof
12/08/2004	EP1483380A2 Recombinant protein c variants
12/08/2004	EP1483379A2 Use of xylene monooxygenase for the oxidation of substituted polycyclic aromatic compounds
12/08/2004	EP1483367A2 Bacteria with reduced genome
12/08/2004	EP1483298A2 Materials and methods for preparing dimeric growth factors
12/08/2004	EP1483297A2 Antibodies derived from anti ed-b l19 and targeting tumor vasculature
12/08/2004	EP1483296A1 Specific ab1'-antibodies against tumour-associated antigen ca 125
12/08/2004	EP1483289A2 Angiogenesis regulator genes, pharmaceutical preparations containing same and uses thereof
12/08/2004	EP1483288A2 Hbm variants that modulate bone mass and lipid levels
12/08/2004	EP1483282A1 RIBOZYMES WITH BROAD tRNA AMINOACYLATION ACTIVITY
12/08/2004	EP1482984A2 Surrogate antibodies and methods of preparation and use thereof
12/08/2004	EP1482793A2 Effect of treatment with 4,5-dihydroxy- 2-cyclopenten-1-one (dhcp) on gene expression and quorum-sensing in bacteria
12/08/2004	EP1444345A4 Conversion of liver stem and progenitor cells to pancreatic functional cells
12/08/2004	EP1056858B1 RECOMBINANT ACTIVE HUMAN ZONA PELLUCIDA PROTEIN 3 (hZP3)
12/08/2004	EP1009767B1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS
12/08/2004	EP0964740B1 Biotechnical process for the preparation of aspartic acid homo- or copolymers
12/08/2004	EP0828847A4 Enzyme catalysis in organic solutions
12/08/2004	EP0824548B1 Hybrid molecules between heat-labile enterotoxin and cholera toxin b subunits
12/08/2004	CN1553961A Membrane virus host range mutations and their uses as vaccine substrates
12/08/2004	CN1553956A Novel genetic products of ashbya gossypii, associated with transmembrane transport
12/08/2004	CN1553813A Complement pathway inhibitors binding to C5 and C5A without preventing formation of C5B
12/08/2004	CN1553807A Compositions comprising mixtures of therapeutic proteins and methods of producing the same
12/08/2004	CN1552894A Corn peptide and its preparation and use
12/08/2004	CN1552893A Brewer's yeast recombined hepatitis B virus surface antigen stream plus addition fermentation
12/08/2004	CN1552892A Physiological active buck peptide by compound proteinase catalysis and use of products thereby
12/08/2004	CN1552891A Preparation of dairy ACE inhibitory peptide
12/08/2004	CN1552890A Method for preparing connective tissue growth factor C-zone antigen
12/08/2004	CN1552889A Use and preparation of collagen protein and collagen polypeptide
12/08/2004	CN1552888A Production of polysaccharide protein by deep fermemtation of hysteriales for anticancer
12/08/2004	CN1552863A Chlorophyll a/b protein composite expression sequence label of tea tree and its biologic chip
12/08/2004	CN1552862A Chlorophyll a/b binding protein expression sequence label of tea tree and biological chip
12/08/2004	CN1552861A Tubulin differential expression sequence label of tea tree and biological chip
12/08/2004	CN1552860A Camellia expansion specific expression sequence label and its biologic chip
12/08/2004	CN1552859A Elongation factor 1 alpha differential expression sequence label of tea tree and biological chip
12/08/2004	CN1552858A Thermal protein differential expression sequence label of tea tree and biological chip
12/08/2004	CN1552857A Brewer's yeast recombined hepatitis B virus surface antigen stream plus addition femrentation
12/08/2004	CN1552856A DNA encoding a plasminogen-activating protein
12/08/2004	CN1552855A Vascular endothelial growth factor 2
12/08/2004	CN1552854A Gene of coding cobweb protein and use thereof
12/08/2004	CN1179040C Cyclic peptides
12/08/2004	CN1179037C Bacillus substilis Var. chungkookjang producing high molecular weight poly-gamma-glutamic acid
12/08/2004	CN1178955C Modified TNF alpha molecules and DNA encoding such modified TNF alpha molecules and vaccines comprising such modified TNF alpha molecules and DNA
12/08/2004	CN1178952C Nucleic acids encoding G-protein coupled receptor involved in sensory transduction
12/08/2004	CN1178950C Corpuscles of stannius protein and stanniocalcin
12/07/2004	US6828424 Nucleotide sequences coding enzymatic polypeptide for use in the treatment of arthritis and cancer; for use as antiscarring agent
12/07/2004	US6828420 Small conductance, calcium-activated potassium channels (SKI)
12/07/2004	US6828418 Stable bactericidal/permeability-increasing protein products and pharmaceutical compositions containing the same
12/07/2004	US6828416 Recombinant multivalent malarial vaccine against Plasmodium falciparum
12/07/2004	US6828150 Antigen presenting system and methods for activation of T-cells
12/07/2004	US6828137 Methods for producing polypeptides in aspergillus mutant cells
12/07/2004	US6828123 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
12/07/2004	US6828122 Nucleotide sequences coding transport protein for use in the treatment of cancer, heart and viral diseases
12/07/2004	US6828121 Genetically engineered cells for use in the generatin of heterologous polypeptides
12/07/2004	US6828114 Monoclonal antibody against apolipoprotein A-I
12/02/2004	WO2004104210A1 Process for producing protein by cell-free protein synthesis system and proten synthesis reagent kit

1 ... 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 ... 1125